https://orcid.org/0000-0002-4590-8085
References
- Wang S, Song R, Wang Z, et al. S100A8/A9 in Inflammation. Front Immunol. 2018;9:1298.
- Johne B, Fagerhol MK, Lyberg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol. 1997;50(3):113–123.
- Urban CF, Ermert D, Schmid M, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5(10):e1000639.
- Lamb CA, Kennedy NA, Raine T, IBD Guidelines eDelphi Consensus Group, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):S1–S106.
- Fukunaga S, Kuwaki K, Mitsuyama K, et al. Detection of calprotectin in inflammatory bowel disease: fecal and serum levels and immunohistochemical localization. Int J Mol Med. 2018;41(1):107–118.
- Malham M, Carlsen K, Riis L, et al. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis. Scand J Gastroenterol. 2019;54(10):1214–1219.
- Nordal HH, Fagerhol MK, Halse AK, et al. Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis. Scand J Clin Lab Invest. 2018;78(1–2):102–108.
- Nevejan L, Strypens T, Van Nieuwenhove M, et al. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta. 2022;525:54–61.
- Cornes M, Simundic AM, Cadamuro J, et al. The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2020;59(1):59–69.
- Dale I. Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scand J Clin Lab Invest. 1990;50(8):837–841.
- Pedersen L, Nybo M, Poulsen MK, et al. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients. BMC Cardiovasc Disord. 2014;14:196.
- Mylemans M, Nevejan L, Van Den Bremt S, et al. Circulating calprotectin as biomarker in neutrophil-related inflammation: pre-analytical recommendations and reference values according to sample type. Clin Chim Acta. 2021;517:149–155.
- Van Hoovels L, Vander Cruyssen B, Bogaert L, et al. Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis. Clin Chem Lab Med. 2019;58(1):40–49.
- Simundic AM, Baird G, Cadamuro J, et al. Managing hemolyzed samples in clinical laboratories. Crit Rev Clin Lab Sci. 2020;57(1):1–21.
- McEnroe R, editor. CLSI. Evaluation of precision of quantitative measurement procedures; Approved guideline - Third Edition. EP05-A3. Wayne, PA: Clinical and Laboratory Standards Institute 2014.
- McEnroe R, editor. CLSI. Interference testing in Clinical Chemistry. 3rd ed. CLSI Guideline EP07 Wayne PA: Clinical and Laboratory Standards Institute 2018.
- Monneret D, Mestari F, Atlan G, et al. Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: determination of allowable interference limits according to different calculation methods. Scand J Clin Lab Invest. 2015;75(2):162–169.
- Nevejan L, Mylemans M, Vander Cruyssen B, et al. Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependent. Clin Chem Lab Med. 2022;60(2):57–60.
- Haisma SM, van Rheenen PF, Wagenmakers L, et al. Calprotectin instability may lead to undertreatment in children with IBD. Arch Dis Child. 2020;105(10):996–998.
- Vicente-Steijn R, Jansen JM, Bisheshar R, et al. Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients. Pract Lab Med. 2020;21(175):e00175.
- Simundic AM, Nikolac N, Ivankovic V, et al. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med. 2009;47(11):1361–1365.